Soft Mist Nasal Administration Device for topical anaesthesia of the nasal cavity

Soft Mist Nasal Administration Device for topical anaesthesia of the nasal cavity - CT1 NAA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON56973

Enrollment

Registered

2024-08-28

Start date

2024-12-15

Completion date

Unknown

Last updated

2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locoregional anesthesia of the nasal cavity Topical anesthesie

Interventions

Lidocaine 4% will be applied intranasally with the NAA before nasal instrumentation. On completion of the procedure the participant and the researcher will be asked to complete a feedback form.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age >18 years - Lean body weight >= 50 kg - ASA physical status 1 or 2

Exclusion criteria

Exclusion criteria: • Inability to cooperate • History of hepatic, renal and coagulation diseases, • Respiratory tract pathology • Obstruction of the nasal passage • Chronic rhinitis • Chronic sinusitis • Pregnancy • Allergy to amide type of local anaesthetics • No written informed consent by subject

Design outcomes

Primary

Measure	Time frame
Studying the level of anesthesia of the nasal mucosa as evaluated and demonstrated with successful awake nasal instrumentation with minimal discomfort for the subject.	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 16, 2026